Researchers from the University of British Columbia developed the method which turns stem cells into insulin-producing cells in about six weeks, far quicker than the four months it took using previous methods.
"We are a step closer to having an unlimited supply of insulin-producing cells to treat patients with Type 1 diabetes," said Timothy Kieffer, who led the research and is a professor in UBC's Department of Cellular and Physiological Sciences and the Department of Surgery.
The conversion is completed after the cells are transplanted into a host.
"We have not yet made fully functional cells in a dish, but we are very close. The cells we make in the lab produce insulin, but are still immature and need the transplant host to complete the transformation into fully functioning cells," said Kieffer.
An important next step for UBC researchers and their industry collaborators is to determine how to prevent the insulin-producing cells from being rejected by the body.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
